Valuation : Captor Therapeutics Spolka Akcyjna

Market Cap 453M 122M 105M 98.79M 90.25M 169M 11.52B 169M 1.17B 5.91B 458M 448M 19.04B P/E 2026 *
23.2x
P/E 2027 * -11.1x
Enterprise Value 380M 102M 88.2M 82.98M 75.8M 142M 9.68B 142M 981M 4.96B 385M 376M 15.99B EV / Sales 2026 *
6.71x
EV / Sales 2027 * 42.1x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 day-0.28%
1 week+0.42%
Current month-0.83%
1 month-2.06%
3 months-5.56%
6 months-14.92%
Current year-0.97%
1 week 68.3
Extreme 68.3
71.9
1 month 67.2
Extreme 67.2
74
Current year 67.2
Extreme 67.2
89.2
1 year 33
Extreme 33
89.2
3 years 31.2
Extreme 31.2
132
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 31/05/2025
Director of Finance/CFO - 01/02/2025
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Chairman 54 30/06/2022
Director/Board Member 74 30/06/2022
Director/Board Member - 30/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
26/02/26 Buy 1,100 0.0198%
12/12/25 Free

Chairman

360,074 6.5128%
12/12/25 Don

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%+0.42%+91.67%-44.30% 122M
-2.54%-2.84%-1.90%+14.52% 50.35B
-0.40%+1.03%+439.20%+499.20% 45.2B
-1.42%+2.30%+45.46%+19.36% 44.71B
-1.22%-2.31%+12.40%+71.48% 41.24B
+0.53%-1.36%+16.04%+48.23% 33.08B
-0.21%+9.14% - - 17.81B
-0.35%-1.56%+22.59%+116.19% 16.56B
-1.01%+0.50%+15.83%+27.98% 14.82B
-1.65%-1.03%+77.75%+37.63% 14B
Average -0.85%+0.50%+79.89%+87.81% 27.79B
Weighted average by Cap. -1.04%+0.26%+94.35%+121.36%

Financials

2026 *2027 *
Net sales 56.7M 15.27M 13.14M 12.37M 11.3M 21.13M 1.44B 21.19M 146M 740M 57.35M 56.1M 2.38B 10M 2.69M 2.32M 2.18M 1.99M 3.73M 254M 3.74M 25.77M 130M 10.12M 9.89M 420M
Net income -3M -808K -695K -654K -598K -1.12M -76.3M -1.12M -7.73M -39.15M -3.03M -2.97M -126M -41M -11.04M -9.5M -8.94M -8.17M -15.28M -1.04B -15.32M -106M -535M -41.47M -40.57M -1.72B
Net Debt -72.5M -19.53M -16.8M -15.81M -14.44M -27.02M -1.84B -27.09M -187M -946M -73.33M -71.73M -3.05B -32M -8.62M -7.42M -6.98M -6.38M -11.93M -814M -11.96M -82.46M -418M -32.37M -31.66M -1.35B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
-
Date Price Change Volume
04/09/26 PLN 71.30 -0.28% 1,337
03/09/26 PLN 71.50 +0.70% 1,176
02/09/26 PLN 71.00 0.00% 2,450
01/09/26 PLN 71.00 -1.25% 1,910
31/08/26 PLN 71.90 +1.27% 2,014
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
71.30PLN
Average target price
86.83PLN
Spread / Average Target
+21.79%

Quarterly revenue - Rate of surprise